Clinical Trials Directory

Trials / Completed

CompletedNCT04085302

TARA Working Prototype Engagement Evaluation: Feasibility Study

Mixed Methods (Quantitative, Qualitative) Feasability Study Assessing Engagement With the First Version of the TARA Working Prototype (a Digital Behaviour Change Intervention, DBCI) in Individuals With COPD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Boehringer Ingelheim · Industry
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

TARA is a Digital Behaviour Change Intervention (DBCI) for individuals with Chronic Obstructive Pulmonary Disease (COPD)(IwCOPD), which has been designed using a Human-Centred Design (HCD) methodology. HCD involves, among other elements, members of the target audience in evaluations at multiple stages within the design process. This feasibility study is primarily designed to assess the acceptability of the DBCI test asset to the target audience. Acceptability as defined for the purpose of this study includes usability of the system, and perceived value and desirability to the end-user audience. As such, engagement in this context is deemed to mean the degree to which the test asset provides a usable, acceptable, desirable and valuable experience to its users during a time-limited trial.

Conditions

Interventions

TypeNameDescription
DEVICEDigital Behaviour Change Intervention14 days

Timeline

Start date
2019-09-26
Primary completion
2019-12-03
Completion
2019-12-03
First posted
2019-09-11
Last updated
2020-09-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04085302. Inclusion in this directory is not an endorsement.